Loading the section…

EMR: financial statements from SEC — TradeAlmanac

EMR

Emerson Electric Company: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Revenue	4.56B	4.35B	4.86B	4.55B	4.43B	4.18B	4.62B	4.38B
Cost of revenue	2.14B	2.04B	—	2.16B	2.06B	1.94B	—	2.07B
Selling, general and administrative	1.32B	1.24B	—	1.27B	1.28B	1.22B	—	1.25B
Pre-tax income	793M	775M	—	734M	629M	775M	—	455M
Income tax	175M	169M	—	154M	199M	182M	—	88M
Net income	618M	605M	637M	586M	485M	585M	996M	329M
Earnings per share	1.10	1.08	1.13	1.04	0.86	1.03	1.74	0.58
Earnings per share, diluted	1.10	1.07	1.12	1.04	0.86	1.02	1.73	0.57
Weighted average shares	561M	562M	—	562M	563M	569M	—	572M
Weighted average shares, diluted	563M	564M	—	565M	565M	571M	—	575M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	1.79B	1.75B	1.54B	2.22B	1.89B	2.83B	3.59B	2.30B
Receivables	3.16B	2.97B	3.10B

Cash flow

Metric	31/03/2026	31/12/2025	30/06/2025	31/03/2025	31/12/2024	30/06/2024
Operating cash flow	—	699M	—	—	777M	—
Depreciation and amortisation	369M	359M	372M	384M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator